Market Access is also used in Pharmacoeconomics and refers to the process by which a company gets a drug to market so that it becomes available for patients. Access is defined as a patient's ability to obtain medical care. Ease of access is determined by such factors as the availability of medical services and their acceptability to the patient, location of health care facilities, the transportation, the hours of operation and cost of care.1 Evidence-Based Market Access (see Evidence-based medicine) refers to a process for producing Market Access reports based on scientific, preferably peer-reviewed and referenced material.